Next
Discover the DERAMAXX® (deracoxib)
Difference.
Once-a-day DERAMAXX® provides strong, 24-hour control of
osteoarthritis pain and inflammation.
Because it effectively controls the everyday pain and inflammation of
osteoarthritis, DERAMAXX can help your dog act more like his “old” self again.
Studies conducted by leading veterinary specialists have shown DERAMAXX works.
In a laboratory study, dogs on DERAMAXX showed a significant
improvement.*
Dogs given deracoxib (the active ingredient in DERAMAXX) could place
more weight on the leg with an inflamed joint than dogs given placebo
tablets or Rimadyl® (carprofen)**. Dogs treated with deracoxib
also had lower lameness scores compared to dogs treated with placebo tablets
or Rimadyl® (carprofen)** as shown in Figure 1.

Figure 1
|
In a field study, dog owners reported improved quality of life.***
The effectiveness and safety of DERAMAXX in controlling osteoarthritis pain and
inflammation was tested in a field study with more than 200 dogs. Dog
owners were asked to evaluate their dogs’ quality of life, lameness and
activity. Significant improvement was seen in all three areas for dogs treated
with DERAMAXX compared to those that received placebo tablets. After 14 days of
treatment, nearly 55% of dogs given DERAMAXX had an improved quality of life
according to their owners. As shown in figure 2, this percentage steadily
increased as the study progressed.

Figure 2
|
These studies show DERAMAXX controls the pain and inflammation of
osteoarthritis, so your pet is more comfortable and can return to being an
active member of the family.
As with all drugs in this class, side effects involving the digestive system, kidneys or liver may occur. These are normally mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for preexisting conditions and regular monitoring are recommended for pets on any medication, including Deramaxx. Use with other NSAIDs or corticosteroids should be avoided.
Click
here for full product information.
*Millis DL, Weigel JP Moyers T, Budnomd FC. The Effect of Deracoxib,
A New COX-2 Inhibitor on the Prevention of Lameness Induced By Chemical
Synovitis in Dogs. {Vet Therapeutic 2002}
** Rimadyl® is a registered trademark of Pfizer.
*** DERAMAXX Chewable Tablets Freedom of Information Summary, Supplemental
NADA 141-203; February 2003. Data on file, Novartis Animal Health US,
Inc.
|